Skip to main content
TipRanks
Go Ultimate75% OFF

VistaGen Therapeutics (VTGN) Q2 2021 Earnings Report

1,155 Followers

VTGN Q2 2021 EPS Results

Actual EPS
-$1.50
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$3.90

VTGN Q2 2021 Revenue Results

Actual Revenue
$334.00K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2021
Date
11/12/2020
Time
After Close
Conference Call
Thursday, November 12, 2020
VTGN Upcoming Earnings

VistaGen Therapeutics's next earnings date is estimated for February 11, 2027, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

VTGN Earnings History

VTGN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 11, 20272027 (Q3)-0.32--0.45――
Nov 13, 20262027 (Q2)-0.38-0.24-0.5455.56% (+0.30)
Aug 14, 20262027 (Q1)-0.36-0.30-0.4736.17% (+0.17)
Jun 15, 20262026 (Q4)-0.34-0.37-0.4313.95% (+0.06)
Feb 12, 20262026 (Q3)-0.49-0.45-0.462.17% (+0.01)
Nov 13, 20252026 (Q2)-0.48-0.54-0.42-28.57% (-0.12)
Aug 07, 20252026 (Q1)-0.47-0.47-0.35-34.29% (-0.12)
Jun 17, 20252025 (Q4)-0.50-0.430.3-243.33% (-0.73)
Feb 13, 20252025 (Q3)-0.51-0.46-0.22-109.09% (-0.24)
Nov 07, 20242025 (Q2)-0.39-0.42-0.6636.36% (+0.24)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed